# XL10E Bafeng (Eight Winds) – Extra Points: Lower limbs

八風 · bā fēng

Location: On the dorsum of the foot, between the toes, 0.5 thumb widths proximal to the margin of the web. these points include xingjian liv-2, neiting st-44 & xiaxi gb-47.

Cautions: Avoid in patients with bleeding disorders.

Canonical page: https://acuiq.com/points/xl10e

## Indications

An indication list is a reference index, not a prescription – see the protocols below for sourced treatments.

Heat, Malaria, Top of Foot Pain, Top of Foot Pain, Headache, Headache, Irregular Periods, Period / Menstruation Irregular, Qi Leg, Qi Leg, Redness, Swelling

## Most often selected alongside XL10E

Sourced protocols in the index pairing each point with this one. Corpus frequency, not a combination to use.

- XL10A (Eight Winds) – 13 protocols
- XL10B (Eight Winds) – 13 protocols
- XL10C (Eight Winds) – 13 protocols
- XL10D (Eight Winds) – 13 protocols
- XL10F (Eight Winds) – 13 protocols
- XL10G (Eight Winds) – 13 protocols
- XL10H (Eight Winds) – 13 protocols
- SP06 (Three Yin Intersection) – 11 protocols

## Protocols using XL10E

| Symptoms | Points | Course | Source | Kind | Caveat |
|---|---|---|---|---|---|
| Neuropathic Pain, Neuropathy Peripheral Chemotherapy-induced, Extremities Numbness | LI04, LI11, ST36, SP06, SP09, KD03, TB05, GB39, LV03, XH03, XL10A, XL10B, XL10C, XL10D, XL10E, XL10F, XL10G, XL10H, XU09A, XU09B, XU09C, XU09D, XU09E, XU09F, XU09G, XU09H | 84 days | doi:10.13703/j.0255-2930.20240222-k0001 | trial | Point selection reported in a published study. |
| Beriberi, Foot Swelling, Itchy Feet | ST36, SP06, SP09, GB34, GB39, XL10A, XL10B, XL10C, XL10D, XL10E, XL10F, XL10G, XL10H | 21 days | doi:10.13703/j.0255-2930.20240425-k0001 | trial | Point selection reported in a published study. |
| Diabetes, Leg Pain, Leg Numbness, Claudication Intermittent, Disease Arterial Lower-extremity | LI04, LI11, ST36, ST40, ST42, SP03, SP06, SP09, KD03, GB34, XL05A, XL05B, XL10A, XL10B, XL10C, XL10D, XL10E, XL10F, XL10G, XL10H | 105 days | doi:10.12659/MSM.909733 | trial | Point selection reported in a published study. |
| Paralysis Facial, Bell's Palsy | ST02, ST04, ST06, ST07, BL02, KD03, XH05, XL10A, XL10B, XL10C, XL10D, XL10E, XL10F, XL10G, XL10H, XU09A, XU09B, XU09C, XU09D, XU09E, XU09F, XU09G, XU09H | 35 days | doi:10.3389/fneur.2022.1088138 | trial | Point selection reported in a published study. |
| Cancer Breast, Neuropathy Peripheral Chemotherapy-induced | ST36, SP06, SP09, GB34, LV03, XL10A, XL10B, XL10C, XL10D, XL10E, XL10F, XL10G, XL10H | 28 days | doi:10.2147/jpr.s526405 | trial | Point selection reported in a published study. |
| Neuropathy Peripheral, Neuropathic Pain | ST36, SP06, KD01, KD03, XL10A, XL10B, XL10C, XL10D, XL10E, XL10F, XL10G, XL10H | 18 days | doi:10.3389/fneur.2022.985499 | trial | Point selection reported in a published study. |
| Peripheral Artery Disease Lower Extremity | LI04, LI11, ST36, ST40, ST42, SP03, SP06, SP09, KD03, GB34, XL05A, XL05B, XL10A, XL10B, XL10C, XL10D, XL10E, XL10F, XL10G, XL10H | 105 days | doi:10.12659/MSM.909733 | trial | Point selection reported in a published study. |
| Peripheral Neuropathy | ST36, SP06, KD01, KD03, XL10A, XL10B, XL10C, XL10D, XL10E, XL10F, XL10G, XL10H | 12 days | doi:10.3389/fneur.2024.1388544 | trial | Point selection reported in a published study. |
| Paresthesia, Neuropathy Peripheral Chemotherapy-induced | LI04, ST36, SP06, BL60, LV03, XL10A, XL10B, XL10C, XL10D, XL10E, XL10F, XL10G, XL10H, XU09A, XU09B, XU09C, XU09D, XU09E, XU09F, XU09G, XU09H | 70 days | doi:10.1016/j.ejon.2022.102171 | trial | Point selection reported in a published study. |
| Neuropathy Peripheral Chemotherapy-induced | LI04, LI11, ST36, SP06, TB05, GB34, LV03, XL10A, XL10B, XL10C, XL10D, XL10E, XL10F, XL10G, XL10H, XU09A, XU09B, XU09C, XU09D, XU09E, XU09F, XU09G, XU09H | – | doi:10.1093/oncolo/oyad065 | trial | Point selection reported in a published study. |
| Neuropathy Diabetic, Neuropathy Diabetic Peripheral | ST34, ST40, SP06, KD03, LV03, XL10A, XL10B, XL10C, XL10D, XL10E, XL10F, XL10G, XL10H | 56 days | doi:10.4239/wjd.v14.i12.1813 | trial | Point selection reported in a published study. |
| Cancer Breast, Neuropathy Peripheral Chemotherapy-induced, Extremities Numbness, Tingling Extremities | LI04, LI11, ST36, SP06, SP09, SI03, TB05, GB34, LV03, XL10A, XL10B, XL10C, XL10D, XL10E, XL10F, XL10G, XL10H, XU09A, XU09B, XU09C, XU09D, XU09E, XU09F, XU09G, XU09H | 28 days | doi:10.1093/oncolo/oyaf262 | trial | Point selection reported in a published study. |
| Bi Syndrome, Fever Rheumatic, Arthritis Rheumatoid, Fibrositis, Neuralgia, Gout, Numbness, Toe Pain, Bi Syndrome, Fever Rheumatic, Arthritis Rheumatoid, Toe Pain | SP04, BL65, XL10A, XL10B, XL10C, XL10D, XL10E, XL10F, XL10G, XL10H | 7 days | sacredlotus.com | web | Point selection published on a website. Not peer-reviewed – check it before relying on it. |

---

AcuiQ-authored prose (symptom and meridian descriptions, the wiki, the auricular crosswalk) is licensed CC-BY-4.0: https://creativecommons.org/licenses/by/4.0/. The assembled protocol compilation is not: build on it with attribution, but do not redistribute it whole as a dataset – https://acuiq.com/terms. The underlying findings are the cited sources' claims – each entry carries its citation; verify against the source before relying on it. Not medical advice: https://acuiq.com/terms